Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine
Status:
Recruiting
Trial end date:
2022-10-08
Target enrollment:
Participant gender:
Summary
Pyrotinib is an important drug for the treatment of breast cancer, but the incidence of
diarrhea is very high. At present, there is no particularly effective drug for diarrhea
induced by pyrotinib. Trying to intervene with traditional Chinese medicine may bring better
results to patients.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital